Pre-clinical therapeutics platform developing a patented aerosol/formulation drug-delivery system (DouTOME) that engineers optimized pharmacokinetic profiles for existing APIs to treat CNS, mental-health and substance-use disorders. Aims to enhance efficacy and improve safety/tolerability for underserved indications such as opioid use disorder, benzodiazepine use disorder, and smoking cessation.